COVID-19

Most pharmacists see a transition from transactional care to more direct patient care responsibilities.

For the acceptance of a combination COVID-19 flu vaccine, the team asked participants whether they would be willing to take a combination COVID-19-flu vaccine as a single-shot every year.

Based on the results, the investigators found that a cloth face covering reduced emissions in all directions to about 2 feet compared to the 4 feet of emissions produced when coughing or speaking with no mask on.

Responses elicited by the pneumococcal vaccine for all 20 serotypes were similar whether administered with the COVID-19 vaccine or with placebo.

Well-designed incentives and education can help address COVID-19 vaccine hesitancy and bolster vaccination rates.

Earlier analyses also demonstrated the same potential of BBV152 against SARS-CoV-2 alpha, beta, delta, zeta, and kappa.

These individuals also receive immunosuppressive drugs that often impair the immune responses to the vaccinations, study results show.

Ensovibep has met the primary endpoint of viral load reduction over 8 days in a phase 2 study, the companies said.

Study strongly supports the CDC’s guidance that booster shots are appropriate for anyone ages 16 and older, and that mRNA vaccines are preferred.

A single shot protects for up to 6 months against breakthrough infections, hospitalizations, and intensive care unit admissions, Johnson & Johnson says.

Out of the 3959 who were a part of the study, 2403 of the individuals were vaccinated and 1556 were unvaccinated.

The recommendations include full immunization, including third doses and/or any approved boosters.

Results of a separate analysis demonstrate that Johnson & Johnson’s booster generated a 41-fold increase in neutralizing antibodies and a 5-fold increase in T-cells against omicron.

A panel of doctors explains whether or not someone can get a different COVID-19 booster from their original vaccinations and how they compare.

Experts discuss who is eligible for COVID-19 booster shots and the misinformation around COVID-19 vaccinations.

In laboratory molecular tests, scientists mix samples with assay reagents in a highly controlled process, but because the reaction conditions are tightly controlled, the tests are both sensitive and selective, according to the researchers.

Tixagevimab co-packaged with cilgavimab is one of the only 2 antibody therapies issued emergency use authorization by the FDA that showed neutralizing activity against omicron and all other variants of concern.

The results of an analysis from investigators from Baylor College of Medicine suggest that supplementation with GlyNAC might be beneficial to those who have the virus.

The study analyzed blood samples taken from individuals infected with COVID-19, those who had been vaccinated with a 2-dose schedule and a third booster dose, and those who had reported previous infection from other COVID-19 variants of concern.

The existing EUA was also amended to reduce the time for booster dose administration from a minimum of 6 months to at least 5 months following completion of the primary COVID-19 vaccine series.

Angela Rasmussen, PhD, and Donald Alcendor, PhD have a conversation on the recent expansion of COVID-19 booster shot usage in eligible populations.

Key opinion leaders debate on the necessity of COVID-19 booster shots.

The FDA has granted emergency use authorization for a COVID-19 at-home test (Roche) and a rapid COVID-19 antigen self-test (Clinitest; Siemens Healthineers).

Individuals receiving the therapy had an 87% reduction in risk for the composite primary endpoint of virus-related hospitalization or all-cause death by day 28.

The study authors sought to determine the proportion of states that elected to follow CDC recommendations by identifying each state’s COVID-19 vaccination webpage through keyword-based internet search and set out to identify information about vaccinations for patients with cancer.